Randomized clinical trials of hormone replacement therapy for treatment or prevention of cardiovascular disease: a review of the findings.
Coronary heart disease (CHD) is the leading cause of death in women. Epidemiologic, mechanistic, and animal-model studies have produced convincing evidence that hormone replacement therapy (HRT) could substantially decrease rates of CHD in women. However, several randomized clinical trials of HRT in women with CHD have been unable to confirm the earlier suggestions of benefit, and there has even been a suggestion of increased CHD risk. This article will review the findings to date of these long-term randomized clinical trials of HRT for prevention or treatment of CHD.
Herrington
David M
DM
Department of Internal Medicine/Cardiology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
Klein
Karen Potvin
KP
D000368:Aged; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control*; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000517:prevention & control; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D008875:Middle Aged; D017698:Postmenopause / Q000187:drug effects; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D012680:Sensitivity and Specificity; D016896:Treatment Outcome